Greg Martini
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Greg Martini
Greg Martini is recorded as CFO at Kyverna Therapeutics, Inc. (KYTX). Kyverna Therapeutics, Inc. reported in an 8-K filed May 18, 2026 that Greg Martini was appointed Chief Financial Officer, effective May 18, 2026.
“Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today announced the appointment of Greg Martini as Chief Financial Officer (CFO), effective May 18, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-18–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kyverna Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Warner Biddle CEO, Board Member
- Christi Shaw Chairman, Board Member
- Gregory Martini CFO, Chief Accounting Officer
- Marc Grasso CFO
- Marc Grasso, M.D. CFO
- Mayo Pujols CTO
- Andrew Miller Board Member
- Andrew Miller, Ph.D. Board Member
- Beth Seidenberg Board Member
- Fred E. Cohen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.